Showing results (11-20 of 259) with videos related to
Sort By:
Pageof 26
Biological Chemistry|January 15, 2013
Beyond anemia: hepcidin, monocytes and inflammationXiaolan Zhang, Brad H RovinClinical Immunology (Orlando, Fla.)|March 1, 2006
Chemokine induction by the adipocyte-derived cytokine adiponectinBrad H Rovin, Huijuan SongArthritis & Rheumatology (Hoboken, N.J.)|February 15, 2022
Expert Perspective: An Approach to Refractory Lupus NephritisSwati Arora, Brad H RovinNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2018
B-cell therapy in lupus nephritis: an overviewSalem Almaani, Brad H RovinClinical Nephrology|December 19, 2017
Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abataceptDavid Dado, Samir Parikh, Isabelle Ayoub, et al.Biochimica Et Biophysica Acta|August 31, 2010
Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokinesXiaolan Zhang, Brad H RovinKidney International|March 22, 2021
The STARMEN trial: rethinking calcineurin inhibitor therapy in membranous nephropathyJürgen Floege, Brad H RovinNephron. Clinical Practice|August 7, 2010
Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?Lee A Hebert, Brad H RovinClinical Immunology (Orlando, Fla.)|May 17, 2015
Proteomics and autoimmune kidney diseaseBrad H Rovin, Jon B KleinAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 14, 2014
Lupus nephritis: the evolving role of novel therapeuticsBrad H Rovin, Samir V ParikhPageof 26